Prostate cancer genetic markers. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy12

Prostate Cell Line, Tumor Tumor Cells, Cultured Chromosomes, Human, Pair 8 Epithelial Cells Neoplastic Stem Cells Seminal Vesicles Cell Line Neoplastic Cells, Circulating Stromal Cells Cell Nucleus Rectum

Organisms5

Mice, Nude Mice, SCID Mice, Transgenic Mice, Inbred BALB C Mice, Inbred C57BL

Diseases31

Prostatic Neoplasms Genetic Predisposition to Disease Prostatic Hyperplasia Neoplasms, Hormone-Dependent Disease Progression Neoplasm Metastasis Adenocarcinoma Prostatic Intraepithelial Neoplasia Bone Neoplasms Neoplasm Invasiveness Breast Neoplasms Neoplasms Lung Neoplasms Carcinoma Neoplasm Recurrence, Local Ovarian Neoplasms Prostatic Neoplasms, Castration-Resistant Colonic Neoplasms Stomach Neoplasms Cell Transformation, Neoplastic Prostatic Diseases Pancreatic Neoplasms Prostatitis Colorectal Neoplasms Neovascularization, Pathologic Urinary Bladder Neoplasms Disease Models, Animal Uterine Cervical Neoplasms Carcinoma, Squamous Cell Neoplastic Cells, Circulating Carcinoma, Non-Small-Cell Lung

Chemicals and Drugs60

Genetic Markers Prostate-Specific Antigen Receptors, Androgen Androgens Androgen Antagonists Tumor Markers, Biological Biological Markers Tosyl Compounds Neoplasm Proteins Antineoplastic Agents Antineoplastic Agents, Hormonal RNA, Messenger Androgen Receptor Antagonists Anilides Dihydrotestosterone Finasteride Metribolone RNA, Small Interfering DNA, Neoplasm Flutamide Anticarcinogenic Agents Cancer Vaccines DNA Primers Taxoids Glutamate Carboxypeptidase II 5-alpha Reductase Inhibitors PTEN Phosphohydrolase Antigens, Neoplasm Testosterone Congeners Antineoplastic Agents, Phytogenic Transcription Factors Testosterone Androstenols 3-Oxo-5-alpha-Steroid 4-Dehydrogenase Nitriles Proto-Oncogene Proteins c-akt Azasteroids Phenylthiohydantoin Tumor Suppressor Protein p53 RNA, Neoplasm Racemases and Epimerases DNA-Binding Proteins MicroRNAs Tumor Suppressor Proteins Cholestenone 5 alpha-Reductase Receptor, erbB-2 Estramustine Leuprolide Glutathione S-Transferase pi Goserelin Receptors, Estrogen Antibodies, Monoclonal Ki-67 Antigen Proto-Oncogene Proteins Nuclear Proteins Enzyme Inhibitors Membrane Proteins DNA Kallikreins Prostatic Secretory Proteins

Analytical, Diagnostic and Therapeutic Techniques and Equipment79

Genome-Wide Association Study Prostatectomy Orchiectomy Early Detection of Cancer Neoplasm Staging Prognosis Chromosome Mapping Neoplasm Grading Reverse Transcriptase Polymerase Chain Reaction Case-Control Studies Risk Factors Polymerase Chain Reaction Immunohistochemistry Gene Expression Profiling Xenograft Model Antitumor Assays Digital Rectal Examination Neoplasm Transplantation Sensitivity and Specificity Transplantation, Heterologous Risk Blotting, Western Prospective Studies Follow-Up Studies Risk Assessment Biopsy Survival Rate Retrospective Studies Survival Analysis Transurethral Resection of Prostate Oligonucleotide Array Sequence Analysis Odds Ratio Treatment Outcome Models, Genetic Sequence Analysis, DNA Predictive Value of Tests Cohort Studies Biopsy, Needle Incidence Reproducibility of Results Transfection Brachytherapy Tissue Array Analysis Multivariate Analysis Tumor Burden Disease-Free Survival Combined Modality Therapy Registries Logistic Models Antineoplastic Combined Chemotherapy Protocols Castration SEER Program Pedigree Radiotherapy Kaplan-Meier Estimate In Situ Hybridization, Fluorescence Models, Biological Molecular Targeted Therapy Nomograms Drug Screening Assays, Antitumor Radiotherapy Dosage Flow Cytometry Radiotherapy, Conformal Questionnaires Immunoenzyme Techniques Disease Models, Animal Gene Knockdown Techniques Real-Time Polymerase Chain Reaction ROC Curve Mass Screening Models, Statistical Crosses, Genetic Confidence Intervals Clinical Trials as Topic Cluster Analysis Genetic Testing DNA Mutational Analysis Radiotherapy, Intensity-Modulated Probability Radiotherapy Planning, Computer-Assisted

Psychiatry and Psychology1

Phenomena and Processes58

Genetic Markers Polymorphism, Single Nucleotide Genetic Predisposition to Disease Gene Expression Regulation, Neoplastic Genotype Polymorphism, Genetic Microsatellite Repeats Alleles Cell Proliferation Apoptosis Genetic Variation Genetic Linkage Sensitivity and Specificity Base Sequence Risk Phenotype Mutation Signal Transduction Gene Frequency Cell Growth Processes Haplotypes Drug Resistance, Neoplasm Down-Regulation Odds Ratio Cell Division Time Factors Cell Survival Promoter Regions, Genetic Cell Movement Transfection DNA Methylation Up-Regulation Chromosomes, Human, Pair 8 Cell Cycle Polymorphism, Restriction Fragment Length Gene Expression Dose-Response Relationship, Drug Linkage Disequilibrium Gene Silencing Genes, Tumor Suppressor Gene Fusion RNA Interference Nomograms Algorithms Quantitative Trait Loci Transcription, Genetic Phosphorylation Diet Phylogeny Heterozygote Cell Differentiation Genome, Human Genetic Loci Genes, Neoplasm Recombination, Genetic Probability Amino Acid Sequence Germ-Line Mutation

Disciplines and Occupations2

Immunohistochemistry Genetics, Population

Anthropology, Education, Sociology and Social Phenomena2

National Cancer Institute (U.S.)Quality of Life

Humanities1

Quality of Life

Information Science13

Base Sequence Molecular Sequence Data Survival Rate Incidence Registries SEER Program Algorithms Radiotherapy, Conformal Questionnaires Phylogeny Radiotherapy, Intensity-Modulated Amino Acid Sequence Radiotherapy Planning, Computer-Assisted

Named Groups5

European Continental Ancestry Group African Americans Survivors African Continental Ancestry Group Asian Continental Ancestry Group

Health Care36

Genome-Wide Association Study Case-Control Studies Risk Factors Sensitivity and Specificity Watchful Waiting Risk Prospective Studies Follow-Up Studies Risk Assessment Survival Rate Retrospective Studies Survival Analysis Odds Ratio Treatment Outcome Predictive Value of Tests Cohort Studies Incidence Reproducibility of Results Multivariate Analysis Age Factors Disease-Free Survival Registries Logistic Models National Cancer Institute (U.S.)SEER Program Kaplan-Meier Estimate Nomograms Questionnaires ROC Curve Mass Screening Models, Statistical Confidence Intervals Clinical Trials as Topic Cluster Analysis Genetic Testing Probability

Geographicals5

United States Japan China Sweden Europe

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Prostatic Neoplasms Prostate Genetic Markers Polymorphism, Single Nucleotide Genetic Predisposition to Disease Genome-Wide Association Study Prostate-Specific Antigen Receptors, Androgen Androgens Cell Line, Tumor Androgen Antagonists Prostatectomy Tumor Markers, Biological Prostatic Hyperplasia Gene Expression Regulation, Neoplastic Biological Markers Orchiectomy Neoplasms, Hormone-Dependent Genotype Early Detection of Cancer Disease Progression Neoplasm Metastasis Adenocarcinoma Mice, Nude Prostatic Intraepithelial Neoplasia Polymorphism, Genetic Microsatellite Repeats Tosyl Compounds Neoplasm Staging Prognosis Bone Neoplasms Chromosome Mapping Neoplasm Invasiveness Alleles Cell Proliferation Neoplasm Grading Reverse Transcriptase Polymerase Chain Reaction Case-Control Studies Risk Factors Neoplasm Proteins Tumor Cells, Cultured Polymerase Chain Reaction Apoptosis Antineoplastic Agents Antineoplastic Agents, Hormonal RNA, Messenger Immunohistochemistry Androgen Receptor Antagonists Gene Expression Profiling Breast Neoplasms Genetic Variation Xenograft Model Antitumor Assays Genetic Linkage Digital Rectal Examination Anilides Neoplasm Transplantation Sensitivity and Specificity Neoplasms Watchful Waiting Base Sequence Dihydrotestosterone Transplantation, Heterologous Finasteride Risk Phenotype Blotting, Western Prospective Studies Mutation Molecular Sequence Data Lung Neoplasms Follow-Up Studies Carcinoma Signal Transduction Risk Assessment Biopsy Gene Frequency Metribolone Survival Rate Retrospective Studies Survival Analysis Transurethral Resection of Prostate Oligonucleotide Array Sequence Analysis Neoplasm Recurrence, Local Cell Growth Processes Ovarian Neoplasms Haplotypes Drug Resistance, Neoplasm RNA, Small Interfering United States Down-Regulation DNA, Neoplasm Prostatic Neoplasms, Castration-Resistant Odds Ratio Flutamide Cell Division Treatment Outcome Anticarcinogenic Agents Time Factors Cell Survival Models, Genetic

No FAQ available that match "prostate cancer genetic markers"